Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04288674 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Leptospirosis Registry - LeptoScope

Study acronym: Leptoscope
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv7
  2. Minor Study title shortened, about 13 wordsv6
  3. Minor 2 versions Re-verified since Apr 27, 2021, no change to tracked fieldsv4-v5
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2020 to Mar 4, 2020
    • Site details revised
    v3
  5. Notable Start date: Feb 2020 to Apr 2020v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Leptospirosis is a worldwide zoonotic diseases caused by pathogenic Leptospira spp. Human are accidental hosts, who acquired infections after exposition to animal urine, contaminated water or soil, infected tissue. Incidence of invasive leptospirosis disease causing acute kidney injury, acute respiratory distress syndrome (ARDS), myocarditis, hepatic dysfunction, hemorrhage and multi-organ failure, is globally increasing and there have been frequent outbreak situation throughout the world. Due to increasing outbreak situations and globally chances in species distributions, a worldwide surveillance in epidemiology and species distribution is urgently needed. The objective of the Leptospirosis Registry - LeptoScope is to overcome the lack knowledge on epidemiology, clinical course, prognostic factors and molecular characteristics for invasive leptospirosis disease.
Trial Details
NCT Number NCT04288674
Lead Sponsor University of Cologne
Conditions
(from sponsor)
Leptospirosis
Related terms Leptospirosis
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov